Sunday, November 1, 2015

Oklahoma: Last of Three Defendants is Sentenced in Wire Fraud Scheme to Market Pharmaceutical Ointment

Friday, October 23, 2015

Last of Three Defendants is Sentenced in Wire Fraud Scheme to Market Pharmaceutical Ointment

Oklahoma City, Oklahoma – LAWRENCE GENE BOTHWELL, 35, of Oklahoma City, TOMMY LYNN RICHARDSON, 53, of Ninnekah, Oklahoma, and KENNETH BOYCE,55, of Pleasant View, Utah, have each been sentenced for their involvement in a fraudulent scheme to market a pharmaceutical ointment, announced Sanford C. Coats, United States Attorney for the Western District of Oklahoma.
Bothwell was the founder of Bothwell Consulting, LLC, an Oklahoma limited liability company and investment firm whose principal place of business was in Oklahoma City. Bothwell, Richardson, and Boyce were executives at Bothwell Consulting. Prior to founding Bothwell Consulting, Bothwell worked for the Massachusetts-based developer and owner of a topical ointment called Menastil to develop a website to market Menastil to a wider consumer base. However, Bothwell never acquired any ownership interest or distribution rights in Menastil.
On June 17, 2014, a federal grand jury returned a 13-count indictment charging Bothwell, Richardson, and Boyce for their  sale of fraudulent debentures.  Specifically, the defendants falsely represented to investors that Bothwell Consulting would use their investments to market Menastil when, in reality, Bothwell Consulting owned no distribution rights to the drug.  Instead, the defendants used the fraudulent proceeds for their own financial benefit.  Investors were also told that these debentures were secured by a multi-million dollar trust, which did not actually exist.
On October 3, 2014, all three defendants pleaded guilty to their involvement in the scheme.  The three men have now been sentenced by United States District Judge Joe Heaton as follows:
  • On May 14, 2015, Bothwell was sentenced to serve 78 months in prison, followed by two years of supervised release, and ordered to pay $1,703,781.68 in restitution.
  • On July 31, 2015,  Boyce was sentenced to serve 30 months in prison, followed by three years of supervised release, and ordered to pay $1,475, 272.97 in restitution.
  • On October 21, 2015, Richardson was sentenced to serve 68 months in prison, followed by two years of supervised release, and ordered to pay $1,698,117.50 in restitution.
This case is the result of an investigation by the Federal Bureau of Investigation and was prosecuted by U.S. Attorney Sanford C. Coats and Assistant U.S. Attorney Julia E. Barry.

USP seeks feedback on | American Pharmacists Association https://www.pharmacist.com/usp-seeks... American Pharmacists Association 7 hours ago - The chapter, General Chapter 797 Pharmaceutical Compounding—Sterile Preparations, is one of two enforceable national standards for compounding

USP seeks feedback on | American Pharmacists Association

https://www.pharmacist.com/usp-seeks...
American Pharmacists Association

FDA Announces New Learning Tool to Advance Understanding of the Drug Regulatory Process

Question of the Day November 1 2015 Should prescription drug information be data-mined for a medical office's and a pharmacies patient population to see how many patients are being prescribed the exact same compounded prescription since 503A addresses the medical needs of individual patients that cannot use FDA-approved products? Why or why not? How probable or improbable is it that a medical office's entire patient population would be intolerant to FDA-approved drugs and need the exact same dose and formula of a compounded drug?

Deerfield-based Baxter to cut 1400 jobs by end of year FinancialSpots.com-12 hours ago ... anesthetic and parenteral nutritional products and increased demand for injectable drug compounding services

Deerfield-based Baxter to cut 1400 jobs by end of year
FinancialSpots.com-12 hours ago
... anesthetic and parenteral nutritional products and increased demand for injectable drug compounding services